Literature DB >> 6445242

Clinical profile of restrictive cardiomyopathy.

J R Benotti, W Grossman, P F Cohn.   

Abstract

The characteristic hemodynamic features of restrictive cardiomyopathy (normal or reduced cardiac index, normal ventricular systolic function, and "dip and plateau" early in diastole) are traditionally associated with pathologic evidence of inflammation, infiltration and fibrosis. Prognosis is usually poor. Nine patients with restrictive hemodynamic features were recently identified in our laboratory; six were males, three were females, and ages ranged from 23-57 years (mean 47 years). Only one was asymptomatic. Chest pain, dyspnea on exertion and fatigue were the most common symptoms. Echocardiography revealed various degrees of left ventricular wall thickening, but no significant pericardial effusion, pericardial thickening or calcification. Mean left ventricular end-diastolic pressure was 25 mm Hg, cardiac index 2.8 l/min/m2 and ejection fraction 0.63. Endomyocardial and pericardial biopsies, obtained in two patients, were normal. Follow-up (mean 22 months, range 16-42 months) revealed no cardiac deaths. These findings support the hypothesis that the restrictive hemodynamic profile does not necessarily indicate the presence of a specific pathologic process in the subendocardium or myocardium and that the prognosis is not necessarily ominous. The common pathophysiologic feature for this syndrome appears to be reduced ventricular diastolic compliance, but the etiology in many cases is unclear.

Entities:  

Mesh:

Year:  1980        PMID: 6445242     DOI: 10.1161/01.cir.61.6.1206

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  Anesthetic management for a patient with restrictive cardiomyopathy.

Authors:  K Sumikawa; T Kato; S Nakano
Journal:  J Anesth       Date:  1987-03-01       Impact factor: 2.078

Review 2.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 3.  Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

Review 4.  Restrictive cardiomyopathy.

Authors:  P T Wilmshurst; D Katritsis
Journal:  Br Heart J       Date:  1990-06

5.  Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy.

Authors:  A P Fitzpatrick; L M Shapiro; A F Rickards; P A Poole-Wilson
Journal:  Br Heart J       Date:  1990-02

6.  Restrictive cardiomyopathy and constrictive pericarditis: non-invasive distinction by digitised M mode echocardiography.

Authors:  J M Morgan; L Raposo; J C Clague; W H Chow; P J Oldershaw
Journal:  Br Heart J       Date:  1989-01

7.  Restrictive cardiomyopathy with pseudotumor formation of the left ventricle.

Authors:  R A Schieber; P R Lurie; H B Neustein
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

8.  Restrictive cardiomyopathies in childhood. Etiologies and natural history.

Authors:  S W Denfield; G Rosenthal; R J Gajarski; J T Bricker; K O Schowengerdt; J K Price; J A Towbin
Journal:  Tex Heart Inst J       Date:  1997

9.  Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy.

Authors:  Lakshmi Sridharan; Brian Wayda; Lauren K Truby; Farhana Latif; Susan Restaino; Koji Takeda; Hiroo Takayama; Yoshifumi Naka; Paolo C Colombo; Mathew Maurer; Maryjane A Farr; Veli K Topkara
Journal:  Circ Heart Fail       Date:  2018-03       Impact factor: 8.790

10.  M-mode echocardiographic findings in children with idiopathic restrictive cardiomyopathy.

Authors:  A V Mehta; P L Ferrer; A S Pickoff; S S Singh; G S Wolff; D S Tamer; O L Garcia; H Gelband
Journal:  Pediatr Cardiol       Date:  1984       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.